Table 4.
Levels of sPOSTN in the MPE group and association with the clinicopathological factors of NSCLC patients
| Clinical variables | Number | sPOSTN (ng/mL) | Mann‐Whitney U test | P |
|---|---|---|---|---|
| Age (y) | ||||
| ≥60 | 32 | 307.6 (279.3,328.9) | 162.000 | 0.429 |
| <60 | 12 | 284.9 (258.3,343.2) | ||
| Gender | ||||
| Male | 30 | 302.7 (280.1,331.8) | 181.000 | 0.465 |
| Female | 14 | 293.0 (249.2,330.2) | ||
| Smoking status | ||||
| Smoker | 23 | 310.6.4 (281.4,338.2) | 176.000 | 0.124 |
| Non‐smoker | 21 | 285.2 (252.5,311.3) | ||
| Histological type | ||||
| Squamous cell carcinoma | 3 | 308.2 (209.6,183.9) | 56.000 | 0.798 |
| Adenocarcinoma | 41 | 297.2 (273.4,328.1) | ||
| Lymph node metastasis | ||||
| Positive | 35 | 296.2 (270.0,314.2) | 107.000 | 0.142 |
| Negative | 9 | 323.8 (287.2,361.4) | ||
| Distant metastases | ||||
| Positive | 35 | 299.4 (270.8,338.2) | 136.000 | 0.532 |
| Negative | 9 | 289.2 (260.0,317.2) | ||
Median (P25, P75) in the parameters in the table.